Andrew Farquharson

Andrew Farquharson is a seasoned professional in the healthcare investment sector, serving as Managing Director at InCube Ventures, LLC since September 2007, where the focus is on impactful healthcare innovations. Farquharson also holds a Managing Director position at VHM Ventures and has been a Board Member at Rani Therapeutics, LLC and WhiteSwell, a company enhancing treatment for acute decompensated heart failure, since 2012 and 2018, respectively. Additionally, Farquharson contributes as a Board Observer at Metagenomi and has extensive experience as a Fellow with the Kauffman Fellows Network and as a Partner/Angel at Halo Fund/The Angels' Forum. Earlier roles include Senior Vice President at Operon Technologies, Inc. and Senior Lead Technician/Shift Manager at Genentech. Educational qualifications include an MBA from Harvard Business School and a BA from the University of California, Berkeley.